Questcor Pharmaceuticals, Inc. (QCOR), Harris Corporation (HRS) & More: Here’s What This $4 Billion Winning Hedge Fund Company Has Bought and Sold

Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) is largely known for its multiple-sclerosis (MS) drug, Acthar, that has sold well in the past, and is being evaluated for many more indications. The stock yields 2.8%, and its dividend was hiked by 25% earlier this year. Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) has its risks, though, such as an investigation into its marketing practices as well as competition. The stock is heavily shorted, but some see it as a bargain.

We should never blindly copy any investor’s moves, no matter how talented the investor. But it can be useful to keep an eye on what smart folks are doing. 13-F forms can be great places to find intriguing candidates for our portfolios.

The article Here’s What This $4 Billion Winning Hedge Fund Company Has Bought and Sold originally appeared on Fool.com.

Longtime Fool contributor Selena Maranjian, whom you can follow on Twitter, owns shares of Corning Incorporated (NYSE:GLW). The Motley Fool recommends Corning and owns shares of it.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.